mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α

Hakan Cam1, John B Easton, Anthony High

  • 1Center for Childhood Cancer, Nationwide Children's Hospital, Columbus, OH 43205, USA.

Molecular Cell
|November 25, 2010
PubMed

Insights

Hypoxia suppresses mTORC1 signaling via ATM-dependent phosphorylation of HIF-1α. This pathway links hypoxic stress to mTORC1 regulation and may play a role in pediatric solid tumor development.

Area of Science:

  • Cellular biology
  • Molecular signaling
  • Oncology

Background:

  • The mechanistic target of rapamycin complex-1 (mTORC1) is a key regulator of cell growth and metabolism.
  • Hypoxia (low oxygen) suppresses mTORC1 signaling, but the precise mechanisms remain unclear.
  • Understanding how hypoxia impacts mTORC1 is crucial for comprehending cellular stress responses.

Purpose of the Study:

  • To elucidate the signaling pathway through which hypoxia suppresses mTORC1.
  • To investigate the direct link between hypoxia-induced stress and mTORC1 regulation.
  • To explore the role of this pathway in pediatric solid tumor development.

Main Methods:

  • Investigated the effect of hypoxia on mTORC1 signaling.
  • Utilized biochemical assays to detect protein phosphorylation.
  • Examined the role of ataxia telangiectasia mutated (ATM) and hypoxia-inducible factor 1-alpha (HIF-1α) in hypoxia-induced mTORC1 suppression.
  • Analyzed pediatric solid tumor xenografts for pathway deregulation.

Main Results:

  • Hypoxia induces ATM-dependent phosphorylation of HIF-1α at serine 696.
  • This phosphorylation event mediates the downregulation of mTORC1 signaling under hypoxic conditions.
  • Deregulation of ATM/HIF-1α/mTORC1 pathways was observed in pediatric solid tumor xenografts.

Conclusions:

  • ATM-dependent HIF-1α phosphorylation is a key mechanism by which hypoxia suppresses mTORC1.
  • This finding establishes a direct link between hypoxic stress and mTORC1 regulation.
  • Dysregulation of this pathway in tumors suggests its importance in pediatric solid tumor development and highlights hypoxic regulation of mTORC1 as a potential therapeutic target.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...